Literature DB >> 10832986

Decreased tear secretion after laser in situ keratomileusis for high myopia.

C Aras1, A Ozdamar, H Bahcecioglu, M Karacorlu, B Sener, S Ozkan.   

Abstract

PURPOSE: To investigate the changes in tear secretion and tear film stability after excimer laser in situ keratomileusis (LASIK) for high myopia.
METHODS: One eye of 28 patients underwent unilateral LASIK for the correction of myopia with spherical equivalent refractions ranging from -6.37 to -18.25 D (mean, -11.98 +/- 3.45 D). Schirmer tear test values without anesthesia at 5 minutes and tear break-up time values were measured 4 weeks after LASIK. Unoperated contralateral eyes were used as a control for each patient. The Schirmer tear test and tear break-up time values were analyzed statistically using the independent t-test.
RESULTS: The mean Schirmer tear test value was 16.17 +/- 2.50 mm in the operated eyes and 21.07 +/- 7.03 mm in the unoperated (control) eyes of the same patients (P = .001). The mean tear break-up time value was 21.0 +/- 3.55 seconds in the operated eyes and 21.27 +/- 6.79 seconds in the control eyes (P = .85).
CONCLUSION: Tear secretion decreased following LASIK probably due to decrease in corneal sensitivity, but tear film stability appeared unaltered.

Entities:  

Mesh:

Year:  2000        PMID: 10832986     DOI: 10.3928/1081-597X-20000501-10

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  3 in total

1.  Treatment of chronic dry eye: focus on cyclosporine.

Authors:  George D Kymionis; Dimitrios I Bouzoukis; Vassilios F Diakonis; Charalambos Siganos
Journal:  Clin Ophthalmol       Date:  2008-12

2.  Incidence and management of symptomatic dry eye related to LASIK for myopia, with topical cyclosporine A.

Authors:  Anastasios John Kanellopoulos
Journal:  Clin Ophthalmol       Date:  2019-03-25

3.  The semaphorin 3A inhibitor SM-345431 accelerates peripheral nerve regeneration and sensitivity in a murine corneal transplantation model.

Authors:  Masahiro Omoto; Satoru Yoshida; Hideyuki Miyashita; Tetsuya Kawakita; Kenji Yoshida; Akiyoshi Kishino; Toru Kimura; Shinsuke Shibata; Kazuo Tsubota; Hideyuki Okano; Shigeto Shimmura
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.